DexCom, Inc.
US ˙ NasdaqGS ˙ US2521311074

SecurityDXCM / DexCom, Inc.
InstitutionBLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A
Latest Disclosed Ownership73,675 shares
Latest Disclosed Value $ 5,950,729
BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A reports 44.18% decrease in ownership of DXCM / DexCom, Inc.

On September 26, 2025 - BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A filed a NPORT-P form disclosing ownership of 73,675 shares of DexCom, Inc. (US:DXCM) valued at $5,950,730 USD as of July 31, 2025. The entity filed a previous NPORT-P on June 26, 2025 disclosing 131,979 shares of DexCom, Inc.. This represents a change in shares of -44.18% during the quarter. The current value of the position is $4,524,382 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-09-26 2025-07-31 NP Dexcom EC US2521311074 73,675 -58,304 -44.18 5,951 -36.84 0.0361
2025-06-26 2025-04-30 NP Dexcom EC US2521311074 131,979 56,415 74.66 9,421 43.58 0.0591
2025-03-27 2025-01-31 NP Dexcom EC US2521311074 75,564 -189,497 -71.49 6,561 -64.88 0.0397
2024-12-26 2024-10-31 NP Dexcom EC US2521311074 265,061 161,510 155.97 18,681 166.04 0.1117
2024-09-27 2024-07-31 NP Dexcom EC US2521311074 103,551 -103,551 -50.00 7,023 -73.38 0.0407
2024-06-27 2024-04-30 NP Dexcom EC US2521311074 207,102 -28,845 -12.23 26,383 -7.86 0.1557
2024-03-27 2024-01-31 NP Dexcom EC US2521311074 235,947 20,876 9.71 28,632 49.87 0.1656
2023-12-27 2023-10-31 NP Dexcom EC US2521311074 215,071 8,066 3.90 19,105 -25.91 0.1171
2023-09-26 2023-07-31 NP Dexcom EC US2521311074 207,005 -51,036 -19.78 25,785 -17.65 0.1408
2023-06-27 2023-04-30 NP Dexcom EC US2521311074 258,041 -77,737 -23.15 31,311 -12.93 0.1711
2023-03-29 2023-01-31 NP Dexcom EC US2521311074 335,778 -49,235 -12.79 35,958 -22.67 0.1888
2022-12-27 2022-10-31 NP Dexcom EC US2521311074 385,013 -73,971 -16.12 46,502 23.43 0.2510
2022-09-27 2022-07-31 NP Dexcom EC US2521311074 458,984 340,259 286.59 37,673 -22.34 0.1817
2022-06-27 2022-04-30 NP Dexcom EC US2521311074 118,725 47,801 67.40 48,509 58.88 0.2205
2022-03-29 2022-01-31 NP Dexcom EC US2521311074 70,924 22,144 45.40 30,531 0.43 0.1235
2021-12-28 2021-10-31 NP Dexcom EC US2521311074 48,780 46,478 2,019.03 30,400 2,463.24 0.1131
2021-09-28 2021-07-31 NP Dexcom EC US2521311074 2,302 -2,013 -46.65 1,187 -28.81 0.0044
2021-06-28 2021-04-30 NP Dexcom EC US2521311074 4,315 -1,151 -21.06 1,666 -18.65 0.0062
2021-03-31 2021-01-31 NP DexCom EC US2521311074 5,466 2,232 69.02 2,049 98.26 0.0081
2020-12-28 2020-10-31 NP DexCom EC US2521311074 3,234 -9,885 -75.35 1,034 -81.92 0.0046
2020-09-28 2020-07-31 NP DexCom EC US2521311074 13,119 752 6.08 5,714 37.83 0.0253
2020-06-26 2020-04-30 NP DexCom EC US2521311074 12,367 12,367 4,145 0.0198
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.